Atrophy Advisor aids in managing GA in AMD by integrating progression and lifespan estimates to guide treatment decisions. GA ...

Demodex blepharitis affects about 58% of patients, necessitating thorough ocular surface examinations for accurate diagnosis ...

Multimodal imaging, including OCT and FAF, is crucial for differentiating between AMD and IRDs, enabling precise diagnosis.

NDA submissions for NCX 470 are planned for the first half of 2026 in the US, with China following shortly after. NCX 470 is ...

Malar edema, the collection of fluid below the infraorbital rim and over the malar eminence, presents a unique challenge to ...

“TED is 5 times more prevalent in women, and because of that, men are often overlooked for the diagnosis,” Nijm said. The ...

They explore how rapid symptom relief affects satisfaction, outline current unmet needs in DED treatment, and share guidance ...

Panelists discuss how higher-dose and dual-pathway anti-VEGF agents enable longer intervals, improved fluid control, and more ...

Panelists discuss how the 8-mg aflibercept formulation improves drying efficacy, extends dosing intervals, and reduces burden ...

Aviceda Therapeutics has released topline results from its phase 2b study, SIGLEC, evaluating AVD-104 in patients with ...

The US Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target action date for ...

Recently reported findings indicate that cenegermin-bkbj ophthalmic solution (Oxervate; Dompé) may perform as an effective ...